Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 10, 2021

SELL
$576.64 - $649.04 $3.75 Million - $4.22 Million
-6,500 Closed
0 $0
Q1 2021

May 12, 2021

SELL
$547.01 - $662.35 $820,515 - $993,525
-1,500 Reduced 18.75%
6,500 $3.71 Million
Q4 2020

Feb 16, 2021

BUY
$510.68 - $643.45 $255,340 - $321,725
500 Added 6.67%
8,000 $4.66 Million
Q3 2020

Nov 13, 2020

BUY
$454.43 - $535.6 $3.41 Million - $4.02 Million
7,500 New
7,500 $3.87 Million
Q1 2020

May 15, 2020

SELL
$320.01 - $409.07 $4.8 Million - $6.14 Million
-15,000 Closed
0 $0
Q4 2019

Feb 13, 2020

SELL
$319.73 - $374.2 $959,190 - $1.12 Million
-3,000 Reduced 16.67%
15,000 $5.55 Million
Q3 2019

Nov 12, 2019

BUY
$304.55 - $345.24 $152,275 - $172,620
500 Added 2.86%
18,000 $5.99 Million
Q2 2019

Aug 14, 2019

SELL
$286.93 - $312.59 $717,325 - $781,474
-2,500 Reduced 12.5%
17,500 $5.47 Million
Q1 2019

May 08, 2019

BUY
$224.3 - $317.41 $1.68 Million - $2.38 Million
7,500 Added 60.0%
20,000 $6.11 Million
Q4 2018

Feb 12, 2019

SELL
$220.1 - $309.0 $1.65 Million - $2.32 Million
-7,500 Reduced 37.5%
12,500 $2.9 Million
Q3 2018

Nov 13, 2018

BUY
$289.28 - $326.15 $723,199 - $815,375
2,500 Added 14.29%
20,000 $6.26 Million
Q2 2018

Aug 06, 2018

BUY
$244.1 - $303.88 $610,250 - $759,700
2,500 Added 16.67%
17,500 $5.05 Million
Q1 2018

May 08, 2018

BUY
$233.97 - $274.11 $584,925 - $685,275
2,500 Added 20.0%
15,000 $3.75 Million
Q4 2017

Feb 08, 2018

BUY
$216.94 - $271.3 $542,350 - $678,250
2,500 Added 25.0%
12,500 $2.98 Million
Q3 2017

Nov 08, 2017

BUY
$212.27 - $242.28 $2.12 Million - $2.42 Million
10,000
10,000 $2.22 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.19B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Sivik Global Healthcare LLC Portfolio

Follow Sivik Global Healthcare LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sivik Global Healthcare LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sivik Global Healthcare LLC with notifications on news.